Pharmacology

1234567891011121314

Next »

Source: DVM NEWSMAGAZINE Pfizer set to release details of Fort Dodge acquisition October 19, 2009 New York -- Pfizer Animal Health is expected to release details of its acquisition of Fort Dodge Animal Health today.

Source: DVM NEWSMAGAZINE Sanofi-aventis acquires Merck's interest in Merial Ltd. September 19, 2009 Whitehouse Station, N.J. -- Global pharmaceutical company Sanofi-aventis is now sole owner of Merial Ltd. after purchasing Merck & Co.?s remaining 50 percent interest for $4 billion.

Source: DVM NEWSMAGAZINE FDA warns of importing, compounding trilostane September 17, 2009 FDA warns against importation or compounding of trilostane following the approval of Vetoryl.

Source: DVM NEWSMAGAZINE Traces of a veterinary dewormer are showing up in seized cocaine September 3, 2009 National Report -- The U.S. Drug Enforcement Admininstration (DEA) reports the veterinary dewormer levamisole is showing up in seized street cocaine.

Source: VETERINARY MEDICINE Maropitant's pharmacokinetics and pharmacology September 1, 2009 By:Lotfi El Bahri, DVM, MSc, PhD Maropitant is a weak base, is highly lipophilic, and belongs to the quinuclidine class.

Source: VETERINARY MEDICINE Maropitant: A novel treatment for acute vomiting in dogs September 1, 2009 By:Lotfi El Bahri, DVM, MSc, PhD Vomiting is one of the most common reasons dogs are presented for veterinary consultation.

Source: DVM NEWSMAGAZINE Iowa State DVMs receive more than $200K for research August 9, 2009 Ames, Iowa -- Researchers at the Iowa State University College of Veterinary Medicine working on developing flu vaccines for swine landed a state grant for nearly $150,000, and other Iowa State veterinary researchers will receive nearly $70,000.

Source: DVM NEWSMAGAZINE FDA approves hyperthyroidism drug June 5, 2009 Overland Park, Kan. -- The Federal Drug Administration (FDA) approved a drug to treat hyperthyroidism in cats.

Source: DVM NEWSMAGAZINE FDA approves Pfizer's Palladia to treat mast-cell tumors in dogs June 3, 2009 Rockville, Md. -- Pfizer's Palladia (Toceranib phosphate) received approval by the Food and Drug Administration (FDA). The drug is the first one developed specifically for the treatment of cancer in dogs, the FDA reported today.

1234567891011121314

Next »